Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stohlman, S. A.
Right arrow Articles by Weiner, L. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stohlman, S. A.
Right arrow Articles by Weiner, L. P.
NEUROLOGY 1981;31:38
© 1981 American Academy of Neurology

Chronic central nervous system demyelination in mice after JHM virus infection

Stephen A. Stohlman and Leslie P. Weiner

From the Departments of Neurology and Microbiology, University of Southern California, School of Medicine, Los Angeles, CA.

The pathogenesis of murine hepatitis virus, strain JHM, was studied in 6- and 12-week-old C57iBL mice. There was 100% mortality in the 6-week-old mice after intracerebral inoculation. The lesions were characterized by necrotizing encephalomyelitis, without demyelination. Intracerebral inoculation of 12-week-old animals, however, resulted in no morbidity or mortality. The 12-week-old animals showed transient virus replication in the brain, spinal cord, and liver, which was cleared by day 14. Histologic examination showed evidence of ongoing demyelination, concomitant remyelination, and hydrocephalus ex vacuo. Although viral antigen was demonstrated by immunofluorescence in the central nervous system of these animals, no infectious virus was recovered, and immunosuppression regimens did not potentiate the disease.

Address correspondence and reprint requests to Dr. Stohiman, 142 McKibben Annex, University of Southern California, 2025 Zonal Avenue, Los Angeles. CA 90033.

This work was supported by US. Public Health Service Grant No. NS 12967 and by funds from the Kroc Foundation.

Accepted for publication March 13, 1980.




This article has been cited by other articles:


Home page
J. Virol.Home page
K. S. Shindler, L. C. Kenyon, M. Dutt, S. T. Hingley, and J. D. Sarma
Experimental Optic Neuritis Induced by a Demyelinating Strain of Mouse Hepatitis Virus
J. Virol., September 1, 2008; 82(17): 8882 - 8886.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
J. Das Sarma, K. Iacono, L. Gard, R. Marek, L. C. Kenyon, M. Koval, and S. R. Weiss
Demyelinating and Nondemyelinating Strains of Mouse Hepatitis Virus Differ in Their Neural Cell Tropism
J. Virol., June 1, 2008; 82(11): 5519 - 5526.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
K. B. Walsh, L. L. Lanier, and T. E. Lane
NKG2D Receptor Signaling Enhances Cytolytic Activity by Virus-Specific CD8+ T Cells: Evidence for a Protective Role in Virus-Induced Encephalitis
J. Virol., March 15, 2008; 82(6): 3031 - 3044.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. B. Walsh, R. A. Edwards, K. M. Romero, M. V. Kotlajich, S. A. Stohlman, and T. E. Lane
Expression of CXC Chemokine Ligand 10 from the Mouse Hepatitis Virus Genome Results in Protection from Viral-Induced Neurological and Liver Disease
J. Immunol., July 15, 2007; 179(2): 1155 - 1165.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
N. De Albuquerque, E. Baig, X. Ma, J. Zhang, W. He, A. Rowe, M. Habal, M. Liu, I. Shalev, G. P. Downey, et al.
Murine hepatitis virus strain 1 produces a clinically relevant model of severe acute respiratory syndrome in a/j mice.
J. Virol., November 1, 2006; 80(21): 10382 - 10394.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
Y. Li, L. Fu, D. M. Gonzales, and E. Lavi
Coronavirus Neurovirulence Correlates with the Ability of the Virus To Induce Proinflammatory Cytokine Signals from Astrocytes and Microglia
J. Virol., April 1, 2004; 78(7): 3398 - 3406.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
A. A. Dandekar, G. F. Wu, L. Pewe, and S. Perlman
Axonal Damage Is T Cell Mediated and Occurs Concomitantly with Demyelination in Mice Infected with a Neurotropic Coronavirus
J. Virol., July 1, 2001; 75(13): 6115 - 6120.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
J. Das Sarma, L. Fu, J. C. Tsai, S. R. Weiss, and E. Lavi
Demyelination Determinants Map to the Spike Glycoprotein Gene of Coronavirus Mouse Hepatitis Virus
J. Virol., October 1, 2000; 74(19): 9206 - 9213.
[Abstract] [Full Text]


Home page
J. Virol.Home page
G. F. Wu and S. Perlman
Macrophage Infiltration, but Not Apoptosis, Is Correlated with Immune-Mediated Demyelination following Murine Infection with a Neurotropic Coronavirus
J. Virol., October 1, 1999; 73(10): 8771 - 8780.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. C. Bergmann, J. D. Altman, D. Hinton, and S. A. Stohlman
Inverted Immunodominance and Impaired Cytolytic Function of CD8+ T Cells During Viral Persistence in the Central Nervous System
J. Immunol., September 15, 1999; 163(6): 3379 - 3387.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
S. Xue, N. Sun, N. Van Rooijen, and S. Perlman
Depletion of Blood-Borne Macrophages Does Not Reduce Demyelination in Mice Infected with a Neurotropic Coronavirus
J. Virol., August 1, 1999; 73(8): 6327 - 6334.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
M. T. Lin, D. R. Hinton, N. W. Marten, C. C. Bergmann, and S. A. Stohlman
Antibody Prevents Virus Reactivation Within the Central Nervous System
J. Immunol., June 15, 1999; 162(12): 7358 - 7368.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. W. Marten, S. A. Stohlman, W. Smith-Begolka, S. D. Miller, E. Dimacali, Q. Yao, S. Stohl, J. Goverman, and C. C. Bergmann
Selection of CD8+ T Cells with Highly Focused Specificity During Viral Persistence in the Central Nervous System
J. Immunol., April 1, 1999; 162(7): 3905 - 3914.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
J. O. Fleming, F. A. K. E. Zaatari, W. Gilmore, J. D. Berne, J. S. Burks, S. A. Stohlman, W. W. Tourtellotte, and L. P. Weiner
Antigenic Assessment of Coronaviruses Isolated From Patients With Multiple Sclerosis
Arch Neurol, June 1, 1988; 45(6): 629 - 633.
[Abstract] [PDF]


Home page
Arch NeurolHome page
S. S. Erlich, J. O. Fleming, S. A. Stohlman, and L. P. Weiner
Experimental Neuropathology of Chronic Demyelination Induced by a JHM Virus Variant (DS)
Arch Neurol, August 1, 1987; 44(8): 839 - 842.
[Abstract] [PDF]


Home page
ScienceHome page
P. Fishman, J. Gass, P. Swoveland, E Lavi, M. Highkin, and Weiss SR
Infection of the basal ganglia by a murine coronavirus
Science, August 30, 1985; 229(4716): 877 - 879.
[Abstract] [PDF]


Home page
Arch NeurolHome page
J. O. Fleming, S. A. Stohlman, and L. P. Weiner
Coronaviruses and Multiple Sclerosis
Arch Neurol, July 1, 1982; 39(7): 455 - 455.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1981 by AAN Enterprises, Inc.